Abstract
Recent years have seen great advances in mass spectrometry and proteomics, the science dealing with the analysis of proteins, their structure and function. A branch of proteomics dealing with naturally occurring peptides is often referred to as peptidomics. Direct analysis of peptides produced by processing or degradation of proteins might be useful for example for detecting and identifying pathogenic and/or biomarker peptides in body fluids like blood. In this paper, we introduce one of the standard protocols for comprehensive analysis of serum-derived peptides, which consists of methods for purification of serum peptides, detection of peptides, pattern recognition and clustering (bioinformatics), and identification of peptide sequences. Peptide identification should be followed by the investigation of their pathogenic roles using for example synthetic peptides and the establishment of their usefulness as bioclinical markers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hudelist, G., Singer, C.F., Pischinger, K.I., Kaserer, K., Manavi, M., Kubista, E., and Czerwenka, K.F. (2006) Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium. Proteomics 6, 1989–2002.
Xiang, Y., Matsui, T., Matsuo, K., Shimada, K., Tohma, S., Nakamura, H., Masuko, K., Yudoh, K., Nishioka, K., and Kato, T. (2007) Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells. Arthritis Rheum. 56, 2018–2030.
Siest, G., Marteau, J.B., Maumus, S., Berrahmoune, H., Jeannesson, E., Samara, A., Batt, A.M., and Visvikis-Siest, S. (2005) Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers. Eur. J. Pharmacol. 527, 1–22.
Devarajan, P. (2007) Emerging biomarkers of acute kidney injury. Contrib. Nephrol. 156, 203–212.
Anderson, N.L. and Anderson, N.G. (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 1, 845–867.
Diamandis, E.P. (2006) Peptidomics for cancer diagnosis: present and future. J. Proteome. Res. 5, 2079–2082.
Villanueva, J., Martorella, A.J., Lawlor, K., Philip, J., Fleisher, M., Robbins, R.J., and Tempst, P. (2006) Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age. Mol. Cell. Proteomics 5, 1840–1852.
Budde, P., Schulte, I., Appel, A., Neitz, S., Kellmann, M., Tammen, H., Hess, R., and Rose, H. (2005) Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes. Comb. Chem. High Throughput Screen 8, 775–781.
Boonen, K., Baggerman, G., D’Hertog, W., Husson, S.J., Overbergh, L., Mathieu, C., and Schoofs, L. (2007) Neuropeptides of the islets of Langerhans: a peptidomics study. Gen. Comp. Endocrinol. 152, 231–241.
Selle, H., Lamerz, J., Buerger, K., Dessauer, A., Hager, K., Hampel, H., Karl, J., Kellmann, M., Lannfelt, L., Louhija, J., Riepe, M., Rollinger, W., Tumani, H., Schrader, M., and Zucht, H.D. (2005) Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer’s disease. Comb. Chem. High Throughput Screen 8, 801–806.
Tammen, H., Schulte, I., Hess, R., Menzel, C., Kellmann, M., and Schulz-Knappe, P. (2005) Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb. Chem. High Throughput Screen 8, 725–733.
Jurgens, M., Appel, A., Heine, G., Neitz, S., Menzel, C., Tammen, H., and Zucht, H.D. (2005) Towards characterization of the human urinary peptidome. Comb. Chem. High Throughput Screen 8, 757–765.
Norden, A.G., Rodriguez-Cutillas, P., and Unwin, R.J. (2007) Clinical urinary peptidomics: learning to walk before we can run. Clin. Chem. 53, 375–376.
Yuan, X. and Desiderio, D.M. (2005) Human cerebrospinal fluid peptidomics. J. Mass Spectrom. 40, 176–181.
Lamerz, J., Selle, H., Scapozza, L., Crameri, R., Schulz-Knappe, P., Mohring, T., Kellmann, M., Khameni, V., and Zucht, H.D. (2005) Correlation-associated peptide networks of human cerebrospinal fluid. Proteomics 5, 2789–2798.
Acknowledgments
We greatly appreciate the help and consent from Bruker Daltonics.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Xiang, Y., Kurokawa, M.S., Kanke, M., Takakuwa, Y., Kato, T. (2010). Peptidomics: Identification of Pathogenic and Marker Peptides. In: Soloviev, M. (eds) Peptidomics. Methods in Molecular Biology, vol 615. Humana Press. https://doi.org/10.1007/978-1-60761-535-4_20
Download citation
DOI: https://doi.org/10.1007/978-1-60761-535-4_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-534-7
Online ISBN: 978-1-60761-535-4
eBook Packages: Springer Protocols